Rare Diseases

Rare Diseases Perspective


Rare Diseases News & Journal Articles

  • Alert FDA Adds Boxed Warning to Ocaliva to Reinforce Correct Dosing Obeticholic acid may be incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, increasing the risk for serious liver injury and death, the FDA says.
  • Sanofi Beats Novo to Buy Ablynx for $4.8 Billion French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.

Medscape Editorial Collaborations